Teleflex (TFX) announced FDA 510(k) clearance of the AC3 Range Intra-Aortic Balloon Pump. Leveraging the patented technology of the AC3 Optimus IABP, the AC3 Range IABP is designed to provide reliable, ongoing IABP support across various patient transport modes, including ambulances and both fixed- and rotary-wing aircrafts. With the 510(k) clearance, the AC3 Range IABP will enter full market release in the United States and will begin shipping to customers in the second quarter of 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TFX:
- Teleflex reports efficacy of Ringer PBC in coronary procedures
- Teleflex updates clinical study data on UroLift System in BPH
- Teleflex’s Uncertain Future: Hold Rating Amidst Market Decline and Spin-Off Skepticism
- DoorDash, TKO Group, Williams-Sonoma, Expand Energy to join S&P 500 on 3/24
- Buy/Sell: Wall Street’s top 10 stock calls this week